IP Library Granted Patent US 12,690,909
Granted Patent B2
US 12,690,909 · App. 18/062,331 · Granted Jul 28, 2026

Tissue treatment system with fluid delivery console

Inventors: Jay Caplan (Boston, MA); Charles Abele (Brookline, MA); Gregory Andrew Dierksen (Brookline, MA); Andrew Hollett (Somerville, MA); Thomas C. Kochem (Watertown, MA); Adam Jaynes (Somerville, MA); Jeffrey Johnson (North Andover, MA); Jeffrey Lesica (Holliston, MA); Sara A. Morneau (Lincoln, MA); Bruno Piazzarolo (Arlington, MA); Jonathan Seidmann (Newton, MA)
Assignee: Fractyl Health, Inc.
A61B18/04A61B18/02A61B2018/00577A61B2018/00642A61B2018/00714A61B2018/0212A61B2018/0262A61B2018/046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,690,909
App. No.
18/062,331
Filed
Dec 6, 2022
Granted
Jul 28, 2026
Kind
B2
Art Unit
3794
USPC
606/27
Abstract

A system for performing a medical procedure in the intestine of a patient comprises a catheter for insertion into the intestine, a console, and a connector configured to operably attach the catheter to the console. The catheter comprises a shaft including a distal portion, and a functional assembly positioned on the distal portion of the shaft. The functional assembly is configured to receive fluid. The console comprises: a fluid reservoir configured to supply the fluid, a first syringe pump assembly configured to deliver the fluid to the functional assembly, a second syringe pump assembly configured to deliver the fluid to the functional assembly, a fluid heater configured to heat the fluid, and a waste fluid reservoir configured to receive the fluid. The system is configured to treat target tissue of the intestine of the patient. Methods of treating target tissue are also provided.

Claims (46)

1 . A system for performing a medical procedure in the intestine of a patient, the system comprising:

a catheter for insertion into the intestine, the catheter comprising:

a shaft including a distal portion, and

a functional assembly positioned on the distal portion of the shaft, wherein the functional assembly is configured to receive fluid;

a console comprising:

a fluid reservoir configured to store the fluid,

a first syringe pump assembly comprising a first syringe and a first plunger configured to retract to draw fluid into the first syringe and to advance to deliver fluid from the first syringe to the functional assembly,

a second syringe pump assembly comprising a second syringe and a second plunger configured to retract to draw fluid into the second syringe and to advance to deliver the fluid from the second syringe to the functional assembly,

a fluid heater comprising a flow path configured to receive fluid in a first direction and in a second, opposite direction configured to heat the fluid flowing through the flow path, and

a waste fluid reservoir configured to receive the fluid from the functional assembly; and

a connector configured to operably attach the catheter to the console;

wherein the console is operable in a heating-and-delivery arrangement in which (i) retraction of the second plunger draws fluid from the functional assembly through the flow path of the fluid heater in the first direction while the fluid heater heats the fluid to produce warmed fluid within the second syringe, and (ii) thereafter, advancement of the second plunger forces the warmed fluid from the second syringe through the flow path of the fluid heater in the second direction while the fluid heater heats the warmed fluid to produce ablative-temperature fluid delivered to the functional assembly; and

wherein the system is configured to treat target tissue of the intestine of the patient.

2 . The system according to claim 1 , wherein the functional assembly comprises a balloon.

3 . The system according to claim 1 , wherein the system is configured to treat the target tissue by:

providing a first volume of the fluid at a temperature below body temperature and recirculating the first volume of the fluid within the functional assembly to cool the target tissue and tissue proximate the target tissue; and

providing a second volume of the fluid at an elevated ablative temperature and recirculating the second volume of the fluid within the functional assembly to ablate the target tissue.

4 . The system according to claim 3 , wherein the system is configured to deliver the first volume of the fluid prior to the delivery of the second volume of the fluid or after the delivery of the second volume of the fluid.

5 . The system according to claim 3 , wherein the system is configured to deliver the first volume of the fluid prior to the delivery of the second volume of the fluid, wherein the system is further configured to deliver a third volume of the fluid after the delivery of the second volume of the fluid, and wherein the third volume of the fluid comprises fluid at a temperature below body temperature that during its delivery cools the target tissue and tissue proximate the target tissue.

6 . The system according to claim 3 , wherein the fluid heater comprises an inline heater, and wherein the console is operable such that the second volume of the fluid is heated by the inline heater via two passes through the inline heater in a first direction during a fill stroke of the second syringe pump assembly and in a second, opposite direction during a dispense stroke of the second syringe pump assembly.

7 . The system according to claim 6 , wherein during the first pass through the inline heater, the inline heater is configured to be powered to a higher level than during the second pass through the inline heater.

8 . The system according to claim 3 , wherein the first volume of the fluid comprises fluid at room temperature.

9 . The system according to claim 3 , wherein the console is operable such that the treatment further comprises delivering a third volume of the fluid to cool the target tissue after the target tissue has been ablated.

10 . The system according to claim 9 , wherein the console is configured to prevent delivery of the second volume of fluid to the functional assembly unless a volume of at least the third volume of the fluid is present in the first syringe pump assembly prior to the delivery of the second volume of fluid to the functional assembly.

11 . The system according to claim 1 , wherein the fluid heater comprises an inline heater, and wherein the fluid heater is configured to be pre-heated prior to delivery of heated fluid to the functional assembly.

12 . The system according to claim 11 , wherein the system is configured to perform multiple treatment steps, and wherein the fluid heater is configured to be pre-heated between each of the multiple treatment steps.

13 . The system according to claim 1 , further comprising a closed-loop control algorithm configured to control the fluid heater.

14 . The system according to claim 1 , wherein the console is configured to determine one or more parameters related to the treatment of the target tissue, and wherein the one or more treatment parameters are selected from the group consisting of: a flow rate; a fluid temperature; an energy level; a pressure; a duration; and combinations thereof.

15 . The system according to claim 1 , wherein the console further comprises a backup power supply, wherein the backup power supply comprises an energy capacity sufficient to allow the system to transition one or more components of the system into a patient-safe mode, and wherein the system is configured to transition from a treatment mode to a patient-safe mode in the event of a power failure during treatment of the target tissue.

16 . The system according to claim 1 , wherein the console is configured to monitor one or more parameters of the system to assess the mechanical integrity of the catheter, and wherein the system is configured to monitor for leaks while fluid at an ablative temperature is being circulated through the functional assembly and to cause cooling fluid to be delivered to the functional assembly upon detection of a leak.

17 . The system according to claim 1 , wherein the system does not comprise more than two syringe pump assemblies configured to deliver fluid to the functional assembly, and wherein the first syringe pump assembly comprises a single syringe and the second syringe pump assembly comprises a single syringe.

18 . The system according to claim 1 , wherein the system is configured to prevent the treatment of target tissue if fluid in the fluid reservoir is not above a minimum volume.

19 . The system according to claim 1 , wherein the system is configured to prevent the treatment of target tissue if space in the waste reservoir is not above a minimum volume.

20 . The system of claim 1 , wherein the console comprises a first temperature sensor positioned proximate a first port of the fluid heater and a second temperature sensor positioned proximate a second port of the fluid heater, the first and second temperature sensors being configured to sense temperatures of fluid entering and exiting the fluid heater; and wherein the console controls power to the fluid heater based on the sensed temperatures.

21 . The system of claim 1 , wherein the fluid heater is operated at a first power level during the retraction of the second plunger and at a second power level during the advancement of the second plunger, the second power level being less than the first power level.

22 . A console for performing a medical procedure in the intestine of a patient, the console comprising:

a connector configured to operably attach to a catheter, the catheter being insertable into the intestine and comprising a balloon configured to receive fluid for thermal ablation;

a fluid reservoir interface configured to receive a fluid reservoir containing the fluid;

a first syringe pump assembly comprising a first syringe and a first plunger configured to retract to draw the fluid into the first syringe and to advance to deliver the fluid from the first syringe to the catheter;

a second syringe pump assembly comprising a second syringe and a second plunger configured to retract to draw the fluid into the second syringe and to advance to deliver the fluid from the second syringe to the catheter;

a fluid heater comprising a flow path in fluid communication with the second syringe pump assembly, the flow path being configured to convey fluid in a first direction and in a second, opposite direction, and the fluid heater being configured to heat fluid flowing through the flow path; and

a waste reservoir interface configured to receive a waste fluid reservoir configured to receive the fluid from the catheter;

wherein the console is operable in a heating-and-delivery arrangement in which (i) retraction of the second plunger draws fluid from the catheter through the flow path of the fluid heater in the first direction while the fluid heater heats the fluid to produce warmed fluid within the second syringe, and (ii) thereafter, advancement of the second plunger forces the warmed fluid from the second syringe through the flow path of the fluid heater in the second direction while the fluid heater heats the warmed fluid to produce ablative-temperature fluid delivered to the catheter;

wherein the console is configured to treat target tissue of the intestine of the patient when the catheter is connected to the connector.

23 . The console of claim 22 , further comprising a first temperature sensor positioned proximate a first port of the fluid heater and a second temperature sensor positioned proximate a second port of the fluid heater, the first and second temperature sensors being configured to sense temperatures of fluid entering and exiting the fluid heater, wherein the console is configured to control power to the fluid heater based on the sensed temperatures.

24 . The console of claim 22 , wherein the console is operable such that the fluid heater is powered at a first power level while the second plunger retracts to draw fluid through the flow path in the first direction, and is powered at a second power level while the second plunger advances to force fluid through the flow path in the second direction, the second power level being less than the first power level.

Assignments (2)
SECURITY INTEREST Recorded Sep 7, 2023
From: FRACTYL HEALTH, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC
Reel/Frame 064840/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2023
From: LEVIN, PHILIP; CAPLAN, JAY; ABELE, CHARLES; DIERKSEN, GREG; HOLLETT, ANDREW; KOCHEM, THOMAS; JAYNES, ADAM; JOHNSON, JEFF; LESICA, JEFF; MACLEAN, LIONEL STEWART; MORNEAU, SARA; PIAZZAROLO, BRUNO; ROSBERG, LEN; SEIDMANN, JONATHAN; FLAHERTY, R. MAXWELL; FLAHERTY, J. CHRISTOPHER
To: FRACTYL HEALTH, INC
Reel/Frame 062642/0197 →
Continuity (3)
Continuation PCTUS2021038371 · Jun 22, 2021
Provisional Application 63042356 · Jun 22, 2020
Related Publication 20230346451A1 · Nov 2, 2023
References Cited (383)
US 5084044A · Quint · 1992 [cited by applicant]
US 5190540A · Lee, I · 1993 [cited by applicant]
US 5423754A · Cornelius et al. · 1995 [cited by applicant]
US 5471982A · Edwards et al. · 1995 [cited by applicant]
US 5496311A · Abele et al. · 1996 [cited by applicant]
US 5515100A · Nogo · 1996 [cited by applicant]
US 5542928A · Evans et al. · 1996 [cited by applicant]
US 5549559A · Eshel · 1996 [cited by applicant]
US 5575772A · Lennox · 1996 [cited by applicant]
US 5704934A · Neuwirth et al. · 1998 [cited by applicant]
US 5730719A · Edwards · 1998 [cited by applicant]
US 5800484A · Gough et al. · 1998 [cited by applicant]
US 5827269A · Saadat · 1998 [cited by applicant]
US 5859037A · Whitcomb et al. · 1999 [cited by applicant]
US 5869037A · Crystal et al. · 1999 [cited by applicant]
US 5871525A · Edwards et al. · 1999 [cited by applicant]
US 5879347A · Saadat et al. · 1999 [cited by applicant]
US 5957962A · Wallsten et al. · 1999 [cited by applicant]
US 5964753A · Edwards · 1999 [cited by applicant]
US 6009877A · Edwards · 2000 [cited by applicant]
US 6053937A · Edwards et al. · 2000 [cited by applicant]
US 6056744A · Edwards et al. · 2000 [cited by applicant]
US 6066132A · Chen et al. · 2000 [cited by applicant]
US 6077257A · Edwards et al. · 2000 [cited by applicant]
US 6112123A · Kelleher et al. · 2000 [cited by applicant]
US 6293909B1 · Chu et al. · 2001 [cited by applicant]
US 6325777B1 · Zadno-Azizi et al. · 2001 [cited by applicant]
US 6325798B1 · Edwards et al. · 2001 [cited by applicant]
US 6338726B1 · Edwards et al. · 2002 [cited by applicant]
US 6358245B1 · Edwards et al. · 2002 [cited by applicant]
US 6402744B2 · Edwards et al. · 2002 [cited by applicant]
US 6405732B1 · Edwards et al. · 2002 [cited by applicant]
US 6409723B1 · Edwards · 2002 [cited by applicant]
US 6425887B1 · McGuckin et al. · 2002 [cited by applicant]
US 6443947B1 · Marko et al. · 2002 [cited by applicant]
US 6544226B1 · Gaiser et al. · 2003 [cited by applicant]
US 6673070B2 · Edwards et al. · 2004 [cited by applicant]
US 6712814B2 · Edwards et al. · 2004 [cited by applicant]
US 6802841B2 · Utley et al. · 2004 [cited by applicant]
US 6905496B1 · Ellman et al. · 2005 [cited by applicant]
US 6962587B2 · Johnson et al. · 2005 [cited by applicant]
US 6974456B2 · Edwards et al. · 2005 [cited by applicant]
US 7077841B2 · Gaiser et al. · 2006 [cited by applicant]
US 7111627B2 · Stack et al. · 2006 [cited by applicant]
US 7122031B2 · Edwards et al. · 2006 [cited by applicant]
US 7125407B2 · Edwards et al. · 2006 [cited by applicant]
US 7156860B2 · Wallsten · 2007 [cited by applicant]
US 7165551B2 · Edwards et al. · 2007 [cited by applicant]
US 7241295B2 · Maguire · 2007 [cited by applicant]
US 7326207B2 · Edwards · 2008 [cited by applicant]
US 7371215B2 · Colliou et al. · 2008 [cited by applicant]
US 7387626B2 · Edwards et al. · 2008 [cited by applicant]
US 7422587B2 · Bek et al. · 2008 [cited by applicant]
US 7507234B2 · Utley et al. · 2009 [cited by applicant]
US 7507238B2 · Edwards et al. · 2009 [cited by applicant]
US 7530979B2 · Ganz et al. · 2009 [cited by applicant]
US 7556628B2 · Utley et al. · 2009 [cited by applicant]
US 7585296B2 · Edward et al. · 2009 [cited by applicant]
US 7632268B2 · Utley et al. · 2009 [cited by applicant]
US 7632291B2 · Stephens et al. · 2009 [cited by applicant]
US 7648500B2 · Edwards et al. · 2010 [cited by applicant]
US 7758623B2 · Dzeng et al. · 2010 [cited by applicant]
US 7762977B2 · Porter et al. · 2010 [cited by applicant]
US 7947038B2 · Edwards · 2011 [cited by applicant]
US 7959627B2 · Utley et al. · 2011 [cited by applicant]
US 7993336B2 · Jackson et al. · 2011 [cited by applicant]
US 7997278B2 · Utley et al. · 2011 [cited by applicant]
US 8012149B2 · Jackson et al. · 2011 [cited by applicant]
US 8066689B2 · Mitelberg et al. · 2011 [cited by applicant]
US 8152803B2 · Edwards et al. · 2012 [cited by applicant]
US 8177853B2 · Stack et al. · 2012 [cited by applicant]
US 8192426B2 · Stern et al. · 2012 [cited by applicant]
US 8251992B2 · Utley et al. · 2012 [cited by applicant]
US 8262610B2 · Duchon et al. · 2012 [cited by applicant]
US 8273012B2 · Wallace et al. · 2012 [cited by applicant]
US 8323229B2 · Shin et al. · 2012 [cited by applicant]
US 8364237B2 · Stone et al. · 2013 [cited by applicant]
US 8377055B2 · Jackson et al. · 2013 [cited by applicant]
US 8486005B2 · Yodfat et al. · 2013 [cited by applicant]
US 8641711B2 · Kelly et al. · 2014 [cited by applicant]
US 8740894B2 · Edwards · 2014 [cited by applicant]
US 8790705B2 · Geigle et al. · 2014 [cited by applicant]
US 9364283B2 · Utley et al. · 2016 [cited by applicant]
US 9555020B2 · Pasricha et al. · 2017 [cited by applicant]
US 9615880B2 · Gittard et al. · 2017 [cited by applicant]
US 9757535B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 9844641B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 10232143B2 · Rajagopalan et al. · 2019 [cited by applicant]
US 10299857B2 · Rajagopalan et al. · 2019 [cited by applicant]
US 10349998B2 · Levin et al. · 2019 [cited by applicant]
US 10610663B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10765474B2 · Kadamus et al. · 2020 [cited by applicant]
US 10864352B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10869718B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10973561B2 · Caplan et al. · 2021 [cited by applicant]
US 10980590B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 10987149B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 11166761B2 · Kadamus et al. · 2021 [cited by applicant]
US 11185367B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 11419659B2 · Levin et al. · 2022 [cited by applicant]
US 20020077594A1 · Chien et al. · 2002 [cited by applicant]
US 20020192162A1 · Green · 2002 [cited by applicant]
US 20030040804A1 · Stack et al. · 2003 [cited by applicant]
US 20030093072A1 · Friedman · 2003 [cited by applicant]
US 20030153905A1 · Edwards et al. · 2003 [cited by applicant]
US 20030233065A1 · Steward et al. · 2003 [cited by applicant]
US 20040082859A1 · Schaer · 2004 [cited by applicant]
US 20040087936A1 · Stern et al. · 2004 [cited by applicant]
US 20040133256A1 · Callister · 2004 [cited by applicant]
US 20040148034A1 · Kagan et al. · 2004 [cited by applicant]
US 20040204768A1 · Geitz · 2004 [cited by applicant]
US 20040215180A1 · Starkebaum et al. · 2004 [cited by applicant]
US 20040215296A1 · Ganz et al. · 2004 [cited by applicant]
US 20040220559A1 · Kramer et al. · 2004 [cited by applicant]
US 20050096638A1 · Starkebaum et al. · 2005 [cited by applicant]
US 20050154386A1 · West et al. · 2005 [cited by applicant]
US 20050165437A1 · Takimoto · 2005 [cited by applicant]
US 20050171524A1 · Stern et al. · 2005 [cited by applicant]
US 20050192652A1 · Cioanta et al. · 2005 [cited by applicant]
US 20050203489A1 · Saadat et al. · 2005 [cited by applicant]
US 20050222558A1 · Baxter et al. · 2005 [cited by applicant]
US 20050245943A1 · Zvuloni et al. · 2005 [cited by applicant]
US 20050251116A1 · Steinke et al. · 2005 [cited by applicant]
US 20050273090A1 · Nieman et al. · 2005 [cited by applicant]
US 20060070631A1 · Scopton et al. · 2006 [cited by applicant]
US 20060118127A1 · Chinn · 2006 [cited by applicant]
US 20060135963A1 · Kick et al. · 2006 [cited by applicant]
US 20060155261A1 · Bek et al. · 2006 [cited by applicant]
US 20060161107A1 · Mantle · 2006 [cited by examiner]
US 20060205992A1 · Lubock et al. · 2006 [cited by applicant]
US 20060229954A1 · Nuno · 2006 [cited by examiner]
US 20060247683A1 · Danek et al. · 2006 [cited by applicant]
US 20060293742A1 · Dann et al. · 2006 [cited by applicant]
US 20070016262A1 · Gross et al. · 2007 [cited by applicant]
US 20070032788A1 · Edwards et al. · 2007 [cited by applicant]
US 20070100355A1 · Bonde et al. · 2007 [cited by applicant]
US 20080045785A1 · Oyatsu · 2008 [cited by applicant]
US 20080091181A1 · Gabbay · 2008 [cited by applicant]
US 20080107744A1 · Chu · 2008 [cited by applicant]
US 20080119788A1 · Winter · 2008 [cited by applicant]
US 20080125760A1 · Gilboa · 2008 [cited by applicant]
US 20080125803A1 · Sadamasa et al. · 2008 [cited by applicant]
US 20080147056A1 · Van et al. · 2008 [cited by applicant]
US 20080207994A1 · Gonon · 2008 [cited by applicant]
US 20080243112A1 · De · 2008 [cited by applicant]
US 20080319504A1 · Loushin et al. · 2008 [cited by applicant]
US 20090012469A1 · Nita · 2009 [cited by applicant]
US 20090012518A1 · Utley et al. · 2009 [cited by applicant]
US 20090018533A1 · Perkins et al. · 2009 [cited by applicant]
US 20090048593A1 · Ganz et al. · 2009 [cited by applicant]
US 20090069805A1 · Fischer et al. · 2009 [cited by applicant]
US 20090270851A1 · Babkin et al. · 2009 [cited by applicant]
US 20100022891A1 · Zuluaga et al. · 2010 [cited by applicant]
US 20100030190A1 · Singh · 2010 [cited by applicant]
US 20100114087A1 · Edwards et al. · 2010 [cited by applicant]
US 20100114325A1 · Yang et al. · 2010 [cited by applicant]
US 20100168561A1 · Anderson · 2010 [cited by applicant]
US 20100168624A1 · Sliwa · 2010 [cited by applicant]
US 20100204673A1 · Miller · 2010 [cited by applicant]
US 20100204688A1 · Hoey et al. · 2010 [cited by applicant]
US 20100217151A1 · Gostout et al. · 2010 [cited by applicant]
US 20100256775A1 · Belhe et al. · 2010 [cited by applicant]
US 20100260703A1 · Yankelson et al. · 2010 [cited by applicant]
US 20110046537A1 · Errico et al. · 2011 [cited by applicant]
US 20110091564A1 · Chu · 2011 [cited by applicant]
US 20110106273A1 · Belhe et al. · 2011 [cited by applicant]
US 20110160648A1 · Hoey · 2011 [cited by applicant]
US 20110172659A1 · Brannan · 2011 [cited by applicant]
US 20110184401A1 · Iwata et al. · 2011 [cited by applicant]
US 20110319809A1 · Smith · 2011 [cited by applicant]
US 20120059364A1 · Baust et al. · 2012 [cited by applicant]
US 20120197245A1 · Burnett et al. · 2012 [cited by applicant]
US 20120203070A1 · Crenshaw · 2012 [cited by examiner]
US 20120271277A1 · Fischell et al. · 2012 [cited by applicant]
US 20120271301A1 · Fischell et al. · 2012 [cited by applicant]
US 20130071466A1 · Chancellor et al. · 2013 [cited by applicant]
US 20130178910A1 · Azamian et al. · 2013 [cited by applicant]
US 20140031773A1 · Mikkaichi · 2014 [cited by applicant]
US 20140074077A1 · Lane · 2014 [cited by applicant]
US 20140088529A1 · Bengtson · 2014 [cited by applicant]
US 20140121646A1 · Lodin et al. · 2014 [cited by applicant]
US 20140135661A1 · Garrison et al. · 2014 [cited by applicant]
US 20140163664A1 · Goldsmith · 2014 [cited by applicant]
US 20140255458A1 · Li et al. · 2014 [cited by applicant]
US 20140324037A1 · Hoey et al. · 2014 [cited by applicant]
US 20150045825A1 · Caplan et al. · 2015 [cited by applicant]
US 20150141987A1 · Caplan et al. · 2015 [cited by applicant]
US 20150148615A1 · Brennan · 2015 [cited by examiner]
US 20150148738A1 · Caplan et al. · 2015 [cited by applicant]
US 20150359594A1 · Ben-Oren et al. · 2015 [cited by applicant]
US 20160008050A1 · Rajagopalan et al. · 2016 [cited by applicant]
US 20160310200A1 · Wang · 2016 [cited by applicant]
US 20160354144A1 · Caplan et al. · 2016 [cited by applicant]
US 20170007310A1 · Rajagopalan · 2017 [cited by examiner]
US 20170165002A1 · Sharma et al. · 2017 [cited by applicant]
US 20170191035A1 · Sia et al. · 2017 [cited by applicant]
US 20170333122A1 · Rajagopalan · 2017 [cited by examiner]
US 20180221622A1 · Rajagopalan et al. · 2018 [cited by applicant]
US 20200060758A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20200060942A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20200138505A1 · Levin et al. · 2020 [cited by applicant]
US 20200155217A1 · Morneau et al. · 2020 [cited by applicant]
US 20200261144A1 · Caplan et al. · 2020 [cited by applicant]
US 20200305972A1 · Kadamus et al. · 2020 [cited by applicant]
US 20200405388A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20210008336A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210085390A1 · Kadamus et al. · 2021 [cited by applicant]
US 20210137995A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210196341A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210299404A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210307816A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20220054180A1 · Rajagopalan et al. · 2022 [cited by applicant]
US 20220071653A1 · Mani et al. · 2022 [cited by applicant]
CA 2666661C · 2015 [cited by applicant]
CN 1771888A · 2006 [cited by applicant]
CN 101212932A · 2008 [cited by applicant]
EP 1698296A1 · 2006 [cited by applicant]
EP 1886634A1 · 2008 [cited by applicant]
EP 3071286A1 · 2016 [cited by applicant]
JP 2002503512A · 2002 [cited by applicant]
JP 2003520068A · 2003 [cited by applicant]
JP 2004500184A · 2004 [cited by applicant]
JP 2006509536A · 2006 [cited by applicant]
JP 2006136726A · 2006 [cited by applicant]
JP 2007502690A · 2007 [cited by applicant]
JP 2008515464A · 2008 [cited by applicant]
JP 2010142661A · 2010 [cited by applicant]
JP 2010533036A · 2010 [cited by applicant]
JP 2011517599A · 2011 [cited by applicant]
JP 2013543423A · 2013 [cited by applicant]
JP 2014503256A · 2014 [cited by applicant]
KR 20080013945A · 2008 [cited by applicant]
WO WO9418896A1 · 1994 [cited by applicant]
WO WO9912489A2 · 1999 [cited by applicant]
WO WO0207628A2 · 2002 [cited by applicant]
WO WO02058577A1 · 2002 [cited by applicant]
WO WO02096327A2 · 2002 [cited by applicant]
WO WO02102453A2 · 2002 [cited by applicant]
WO WO03033045A2 · 2003 [cited by applicant]
WO WO03092609A2 · 2003 [cited by applicant]
WO WO2004064600A2 · 2004 [cited by applicant]
WO WO2006020370A2 · 2006 [cited by applicant]
WO WO2007044244A2 · 2007 [cited by applicant]
WO WO2007067919A2 · 2007 [cited by applicant]
WO WO2008002654A2 · 2008 [cited by applicant]
WO WO2010042461A1 · 2010 [cited by applicant]
WO WO2010125570A1 · 2010 [cited by applicant]
WO WO2011060301A1 · 2011 [cited by applicant]
WO WO2012009486A2 · 2012 [cited by applicant]
WO WO2012099974A2 · 2012 [cited by applicant]
WO WO2013130655A1 · 2013 [cited by applicant]
WO WO2013134541A2 · 2013 [cited by applicant]
WO WO2013159066A1 · 2013 [cited by applicant]
WO WO2014022436A1 · 2014 [cited by applicant]
WO WO2014026055A1 · 2014 [cited by applicant]
WO WO2014055997A1 · 2014 [cited by applicant]
WO WO2014070136A1 · 2014 [cited by applicant]
WO WO2015038973A1 · 2015 [cited by applicant]
WO WO2015077571A1 · 2015 [cited by applicant]
WO WO2015148541A1 · 2015 [cited by applicant]
WO WO2016011269A1 · 2016 [cited by applicant]
WO WO2017004432A1 · 2017 [cited by applicant]
WO WO2018089773A1 · 2018 [cited by applicant]
WO WO2019018362A1 · 2019 [cited by examiner]
WO WO2019136240A1 · 2019 [cited by applicant]
WO WO2020205844A1 · 2020 [cited by applicant]
WO WO2021081072A1 · 2021 [cited by applicant]
WO WO2021146190A1 · 2021 [cited by applicant]
WO WO2021146535A1 · 2021 [cited by applicant]
WO WO2021188781A1 · 2021 [cited by applicant]
WO WO2021262646A1 · 2021 [cited by applicant]
EP21828461.0 European Search Report and Opinion dated Jun. 28, 2024. [cited by applicant]
Adams, et al. Theoretical design and evaluation of endoluminal ultrasound applicators for thermal therapy of pancreatic cancer under image guidance. AIP Conference Proceedings 1821, 110002 (2017); doi: http://dx.doi.org… [cited by applicant]
Chathadi, et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. Nov. 2015;82(5):773-81. doi: 10.1016/j.gie.2015.06.027. Epub Aug. 7, 2015. [cited by applicant]
Cherrington, et al. Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease. Gastrointest Endosc Clin N Am. Apr. 2017;27(2):299-311. doi: 10.1016/j.giec.2016.12.002. [cited by applicant]
EP12736438.8 The Extended European Search Report dated Nov. 22, 2016. [cited by applicant]
EP14844285.8 The Extended European Search Report dated Apr. 25, 2017. [cited by applicant]
EP20150391.9 The Extended European Search Report dated Aug. 20, 2020. [cited by applicant]
EP20159816.6 The Extended European Search Report dated Aug. 17, 2020. [cited by applicant]
European search report and search opinion dated Mar. 8, 2016 for EP Application No. 13825257.2. [cited by applicant]
European search report and search opinion dated Mar. 17, 2016 for EP Application No. 13827149.9. [cited by applicant]
European search report and search opinion dated Aug. 4, 2015 for EP Application No. 13755156.0. [cited by applicant]
European Search Report and Search Opinion dated Aug. 7, 2017 for European Patent Application No. EP14864511.2. [cited by applicant]
European Search Report and Search Opinion dated Aug. 7, 2017 for European Patent Application No. EP15768945.6. [cited by applicant]
European search report and search opinion dated Nov. 25, 2015 for EP Application No. 13777572.2. [cited by applicant]
European search report with written opinion dated Feb. 1, 2018 for EP Application No. 15822378. [cited by applicant]
European search report with written opinion dated Dec. 2, 2016 for EP Application No. 14807116. [cited by applicant]
Final Office action dated Mar. 22, 2019 for U.S. Appl. No. 14/917,243. [cited by applicant]
Final Office action dated Apr. 5, 2019 for U.S. Appl. No. 14/609,334. [cited by applicant]
Final Office action dated Jun. 17, 19 for U.S. Appl. No. 14/609,332. [cited by applicant]
Final Office action dated Jul. 10, 2019 for U.S. Appl. No. 15/274,948. [cited by applicant]
Galvao Neto, et al. Endoscopic Duodenal Mucosal Resurfacing Improves Glycemic and Hepatic Parameters in Patients With Type 2 Diabetes: Data From a First-in-Human Study. Gastroenterology. 829. Apr. 2016, vol. 150, Issue … [cited by applicant]
Grikscheit, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg., 2004, 240:748-754. [cited by applicant]
International search report and written opinion dated Feb. 20, 2015 for PCT Application No. US2014/711601. [cited by applicant]
International search report and written opinion dated Jun. 21, 2013 for PCT Application No. US2013/028082. [cited by applicant]
International search report and written opinion dated Jun. 26, 2015 for PCT Application No. US2015/022293. [cited by applicant]
International search report and written opinion dated Jul. 13, 2012 for PCT Application No. US2012/021739. [cited by applicant]
International search report and written opinion dated Aug. 8, 2013 for PCT Application No. US2013/037485. [cited by applicant]
International Search Report and Written Opinion dated Sep. 22, 2016 for International PCT Patent Application No. PCT/US2016/040512. [cited by applicant]
International search report and written opinion dated Oct. 23, 2015 for PCT/US2015/040775. [cited by applicant]
International search report and written opinion dated Nov. 8, 2013 for PCT Application No. US2013/052786. [cited by applicant]
International search report and written opinion dated Nov. 11, 2013 for PCT Application No. US2013/054219. [cited by applicant]
International search report and written opinion dated Dec. 24, 2014 for PCT Application No. US2014/055514. [cited by applicant]
International search report and written opinion dated Dec. 30, 2013 for PCT Application No. US2013/063753. [cited by applicant]
International search report dated Dec. 3, 2014 for PCT Application No. US2014/040957. [cited by applicant]
International search report with written opinion dated Jan. 9, 2018 for PCT/US2017/061074. [cited by applicant]
Miyawaki, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. Jul. 2002;8(7):738-42. Epub Jun. 17, 2002. [cited by applicant]
Notice of Allowance dated Jul. 7, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Notice of Allowance dated Sep. 14, 2017 for U.S. Appl. No. 15/274,809. [cited by applicant]
Office Action date Jul. 11, 2018 for U.S. Appl. No. 14/917,243. [cited by applicant]
Office Action date Aug. 9, 2018 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Jan. 8, 2018 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Jan. 13, 2017 for U.S. Appl. No. 14/609,332. [cited by applicant]
Office action dated Feb. 29, 2016 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office action dated Mar. 7, 2019 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office Action dated Mar. 7, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Office Action dated Mar. 7, 2017 for U.S. Appl. No. 15/274,809. [cited by applicant]
Office action dated Mar. 7, 2019 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Mar. 12, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Mar. 19, 2018 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office Action dated Mar. 23, 2017 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Mar. 28, 2016 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Apr. 4, 2018 for U.S. Appl. No. 15/156,585. [cited by applicant]
Office action dated May 16, 19 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated May 18, 2018 for U.S. Appl. No. 14/956,710. [cited by applicant]
Office Action dated May 31, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Office action dated Jun. 6, 2019 for U.S. Appl. No. 15/683,713. [cited by applicant]
Office Action dated Jun. 21, 2017 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office Action dated Jun. 21, 2017 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Jun. 30, 2017 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office action dated Aug. 5, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Sep. 7, 2018 for U.S. Appl. No. 14/609,332. [cited by applicant]
Office Action dated Sep. 23, 2016 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated Oct. 4, 2018 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office Action dated Oct. 7, 2016 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office Action dated Nov. 2, 2017 for U.S. Appl. No. 15/156,585. [cited by applicant]
Office action dated Nov. 2, 2018 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Nov. 15, 2016 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office action dated Nov. 16, 2017 for U.S. Appl. No. 14/609,332. [cited by applicant]
Office action dated Nov. 30, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Nov. 30, 2017 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Dec. 17, 2015 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated Dec. 18, 2017 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated Dec. 18, 2018 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office action dated Dec. 19, 2017 for U.S. Appl. No. 13/945,138. [cited by applicant]
PCT/US14/66829 International Search Report dated Feb. 20, 2015. [cited by applicant]
PCT/US2019/012338 International Search Report dated Apr. 15, 2019. [cited by applicant]
PCT/US2021/038371 International Search Report and Written Opinion dated Oct. 1, 2021. [cited by applicant]
Rajagopalan, et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. Diabetes Care Dec. 2016; 39(12): 2254-2261. http… [cited by applicant]
Rubino, et al. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. Nov. 2002;236(5):554-9. [cited by applicant]
Sarriá, et al. Morphometric study of the layers of the canine small intestine at five sampling sites. Vet J. Jun. 2012;192(3):498-502. doi: 10.1016/j.tvjl.2011.06.041. Epub Nov. 3, 2011. [cited by applicant]
Semkova, et al. Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad … [cited by applicant]
Sen, et al. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther. Oct. … [cited by applicant]
Tolman, et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes care 30.3 (2007): 734-743. [cited by applicant]
Tomizawa, et al. Clinical Outcome of Endoscopic Mucosal Resection (EMR) of Sporadic, Non-Ampullary Duodenal Adenoma (SNADA) : Predictor Analysis of Safety and Efficacy From a High Volume U.S. Tertiary Referral Center. G… [cited by applicant]
U.S. Appl. No. 14/917,243 Office Action dated Jun. 5, 2020. [cited by applicant]
U.S. Appl. No. 13/945,138 Notice of Allowance dated Dec. 22, 2020. [cited by applicant]
U.S. Appl. No. 14/515,324 Office Action dated Dec. 4, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Notice of Allowance dated Dec. 10, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Office Action dated Oct. 29, 2020. [cited by applicant]
U.S. Appl. No. 14/673,565 Office Action dated Dec. 24, 2020. [cited by applicant]
U.S. Appl. No. 14/673,565 Office Action dated Jun. 12, 2020. [cited by applicant]
U.S. Appl. No. 15/274,948 Notice of Allowance dated May 14, 2020. [cited by applicant]
U.S. Appl. No. 15/274,948 Office Action dated Nov. 20, 2018. [cited by applicant]
U.S. Appl. No. 15/406,572 Notice of Allowance dated Oct. 28, 2020. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Apr. 14, 2020. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Feb. 7, 2019. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Nov. 15, 2019. [cited by applicant]
U.S. Appl. No. 15/917,480 Notice of Allowance dated Dec. 17, 2020. [cited by applicant]
U.S. Appl. No. 15/917,480 Office Action dated Nov. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/267,771 Notice of Allowance dated Aug. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/711,236 Office Action dated Dec. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/900,563 Notice of Allowance dated Dec. 17, 2020. [cited by applicant]
U.S. Appl. No. 16/900,563 Office Action dated Nov. 9, 2020. [cited by applicant]
U.S. Appl. No. 13/945,138 Office Action dated Dec. 10, 2019. [cited by applicant]
U.S. Appl. No. 14/515,324 Office Action dated Mar. 31, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Office Action dated Jan. 8, 2020. [cited by applicant]
U.S. Appl. No. 15/683,713 Notice of Allowance dated Mar. 10, 2020. [cited by applicant]
U.S. Appl. No. 15/683,713 Notice of Allowance dated Nov. 27, 2019. [cited by applicant]
U.S. Appl. No. 15/683,713 Office Action dated Oct. 10, 2019. [cited by applicant]
U.S. Appl. No. 15/917,480 Office Action dated Jan. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/267,771 Office Action dated Feb. 6, 2020. [cited by applicant]
Van Baar, et al. Single Catheter for Duodenal Mucosal Resurfacing Demonstrates Similar Safety Profile with Improved Procedure Time when Compared to Original Dual Catheter: Multicenter Study of Subjects with Type 2 Diabe… [cited by applicant]